GENinCode Plc (LON:GENI – Get Free Report)’s share price was up 16.8% on Wednesday . The stock traded as high as GBX 9.20 ($0.12) and last traded at GBX 9.20 ($0.12). Approximately 182,888 shares changed hands during trading, a decline of 37% from the average daily volume of 289,560 shares. The stock had previously closed at GBX 7.88 ($0.10).
GENinCode Stock Up 16.8 %
The stock has a market cap of £16.28 million, a PE ratio of -134.25 and a beta of 0.66. The company has a debt-to-equity ratio of 6.74, a current ratio of 5.92 and a quick ratio of 15.89. The business has a fifty day moving average of GBX 6.35 and a 200-day moving average of GBX 5.91.
About GENinCode
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology provides patients and physicians with preventative care and treatment strategies.
Further Reading
- Five stocks we like better than GENinCode
- Do ETFs Pay Dividends? What You Need to Know
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- How to Calculate Inflation Rate
- Generac Powers Ahead on the Electrification Mega-Trend
- The 3 Best Retail Stocks to Shop for in August
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
